🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether olopatadine nasal spray i...
Status
Completed
Location
Waco
Start Date
2006-12
Trial ID
NCT00578331
Treatments Being Tested
People who have hayfever or allergic rhinitis often complain about eye symp...
Status
Completed
Location
The University of Chicago
Start Date
2009-11
Trial ID
NCT01007253
Treatments Being Tested
A study to demonstrate the superiority of test article nasal spray relative...
Status
Completed
Location
Kenilworth/IL
Start Date
2007-09
Trial ID
NCT00578929
Treatments Being Tested
The purpose of this study is to evaluate the onset of action of fluticasone...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01076439
Treatments Being Tested
A single-center, double-blind, placebo-controlled study of FDC olopatadine ...
Status
Completed
Location
Glenmark Investigational Site 1
Start Date
2014-01-27
Trial ID
NCT03444506
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
Study to evaluate the two different strengths and dose regimen of GSP 301 t...
Status
Completed
Location
Glenmark Investigational Site 10
Start Date
2014-12
Trial ID
NCT02318303
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
The purpose of the study is to assess the safety of the study drug, Patanas...
Status
Completed
Location
Niran Amar, M.D.
Start Date
2008-10
Trial ID
NCT00794144
Treatments Being Tested
This study is to assess the Onset of Action and Efficacy of azelastine hydr...
Status
Completed
Location
Cliantha Research
Start Date
2023-10-30
Trial ID
NCT06126952